Subscribe
Sign In
Tag: CBT > CBD DEA: Page 2
Legislation and Regulation
DEA Proposes New Hemp and CBD Regulations to Comply with 2018 Farm Bill
The DEA emphasizes the new rules are only to conform to the 2018 Farm Bill and have already taken effect.
August 21, 2020
Adult-Use Legalization Bill
Congressional Committee Hearing Navigates the Catch-22 of Cannabis Research
The far-reaching committee hearing was convened to discuss six cannabis reform proposals currently undergoing congressional consideration.
January 17, 2020
Legislation and Regulation
Akers Bio Forms Advisory Board to Explore Involvement in the Hemp and Minor Cannabinoid Market
Recent FDA statements on the danger of CBD products in the open market and the need for DEA-regulated testing have given companies like Akers Bio an opportunity to explore a role in hemp and minor cannabinoid testing and processing.
December 6, 2019
Finance
Bragar Eagel & Squire, P.C. Is Investigating Curaleaf Holdings, Inc. on Behalf of Stockholders, Encourages Investors to Contact the Firm
The investigation concerns whether Curaleaf has violated the federal securities laws and/or engaged in other unlawful business practices.
August 2, 2019
Previous Page
Page 2 of 2